BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4259631)

  • 1. The physiological disposition of 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.
    Chadwick M; Rogers WI
    Cancer Res; 1972 May; 32(5):1045-56. PubMed ID: 4259631
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative physiologic dispositions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.
    Chadwick M; Chang C
    Cancer Treat Rep; 1976 Jul; 60(7):845-55. PubMed ID: 137772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of 5-fluorouracil-2- 14 C and its metabolites in a murine glioma.
    Levin VA; Chadwick M; Little AD
    J Natl Cancer Inst; 1972 Dec; 49(6):1577-84. PubMed ID: 4265113
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5'-monophosphate and 2-deoxyuridine 5'-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors.
    Klubes P; Connelly K; Cerna I; Mandel HG
    Cancer Res; 1978 Aug; 38(8):2325-31. PubMed ID: 667828
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of antileukemic (L1210) treatment schedule on disposition of (minus)-emetine hydrochloride (NSC 33669) in normal and leukemic mice.
    Auletta AE; Gery AM; Mead JA
    Cancer Res; 1974 Jul; 34(7):1581-5. PubMed ID: 4833911
    [No Abstract]   [Full Text] [Related]  

  • 6. A model for prediction of chemotherapy response to 5-fluorouracil based on the differential distribution of 5-[18F]fluorouracil in sensitive versus resistant lymphocytic leukemia in mice.
    Shani J; Wolf W
    Cancer Res; 1977 Jul; 37(7 Pt 1):2306-8. PubMed ID: 861951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographic study of the fate of diazepam-C 14 in the monkey brain.
    Idänpään-Heikkilä JE; Taska RJ; Allen HA; Schoolar JC
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):68-77. PubMed ID: 5001320
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of the antitumor action of 5-fluorouracil (FU).
    Mandel HG; Klubes P; Fernandes DJ
    Bull Cancer; 1979; 66(1):49-54. PubMed ID: 420946
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: studies with intact cells.
    Shrecker AW; Urshel MJ
    Cancer Res; 1968 Apr; 28(4):793-801. PubMed ID: 5649066
    [No Abstract]   [Full Text] [Related]  

  • 10. The nucleotides of fluorinated pyrimidines and their biological activities.
    Heidelberger C
    Ciba Found Symp; 1971; 2():125-40. PubMed ID: 4268154
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inactivation of 5-fluorouracil by tissue homogenates and cell organelles].
    Tugarinov OA; Smolianskaia AZ
    Vopr Onkol; 1973; 19(2):63-8. PubMed ID: 4763788
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the pharmacokinetics of 5-fluorouracil-2-C14].
    Gilev AP; Meĭrena DV; Khagi KhB; Koptelova MN; Shafro EA
    Biull Eksp Biol Med; 1974 Dec; 78(12):39-41. PubMed ID: 4441656
    [No Abstract]   [Full Text] [Related]  

  • 13. Disposition of arabinosylcytosine (NSC-63878) and 6-THIOGUANINE (NSC-752) in solid L1210 leukemia tumor-bearing mice.
    Pittillo RF; Woolley C
    Cancer Chemother Rep; 1973; 57(3):275-89. PubMed ID: 4201593
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of free ribonucleotide pool in the spleens of C57BL and DBA/2 mice and in leukemia cells sensitive and resistant to 5-fluorouracil].
    Gerasimova GK; Mokina VD; Sidorova TA
    Biokhimiia; 1978 Jan; 43(1):163-9. PubMed ID: 623843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo.
    Spears CP; Shani J; Shahinian AH; Wolf W; Heidelberger C; Danenberg PV
    Mol Pharmacol; 1985 Feb; 27(2):302-7. PubMed ID: 2578605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of uracil derivatives on phosphorylation of arabinosylcytosine.
    Grindey GB; Saslaw LD; Waravdekar VS
    Mol Pharmacol; 1968 Jan; 4(1):96-103. PubMed ID: 5640783
    [No Abstract]   [Full Text] [Related]  

  • 17. [Distribution of 5-fluorouracil in the blood and organs of mice].
    Agadzhanova NN; Smolianskaia AZ; Tugarinov OA
    Vopr Onkol; 1969; 15(2):57-61. PubMed ID: 5787532
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation of cytidine 3',5'-monophosphate from mammalian tissues and body fluids and its effects on leukemia L-1210 cell growth in culture.
    Bloch A
    Adv Cyclic Nucleotide Res; 1975; 5():331-8. PubMed ID: 165674
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: nucleoside and nucleotide kinases in cell-free extracts.
    Schrecker AW
    Cancer Res; 1970 Mar; 30(3):632-41. PubMed ID: 5425288
    [No Abstract]   [Full Text] [Related]  

  • 20. Nucleotide formation as adeterminant of 5-fluorouracil response in mouse leukemias.
    Kessel D; Hall TC; Wodinsky I
    Science; 1966 Nov; 154(3751):911-3. PubMed ID: 6003540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.